Tryp Therapeutic Stock Price, News & Analysis
Company Description
Tryp Therapeutic (OTC: TRYPF) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.
TRYPF stock has declined 100.0% over the past year. Shares last traded at $0.0562.
This page provides a comprehensive overview of TRYPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Tryp Therapeutic (TRYPF) stock last traded at $0.0562. Over the past 12 months, the stock has lost 100.0%.
Latest News
Tryp Therapeutic has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, private placement. View all TRYPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TRYPF Company Profile & Sector Positioning
Tryp Therapeutic (TRYPF) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.